New evidence demonstrates link between smoking, prostate cancer prognosis
the ONA take:
The association between smoking and the development of various forms of cancer are well established; however, evidence of such a link with prostate cancer is contradictory.
Now, an international study led by MedUni Vienna and Basle University Hospital has found evidence of a clear link.
The study combined data on 7,191 patients with prostate cancer who underwent radical prostatectomy, with no preoperative treatments.
The results showed that risk of biochemical recurrence of prostate for smokers and ex-smokers was twice that of nonsmokers. However, this negative effect can be offset within 10 years of quitting.
Although this research still does not clarify, in scientific terms, whether smoking is associated with the development of prostate cancer, it does demonstrate that smoking increases the risk of dying from the disease.
The researchers acknowledge that further research is needed, but stress the significance of quitting smoking even for those who are already suffering from prostate cancer.
Association between smoking and development of various forms of cancer well established; however, evidence of prostate cancer link contradictory.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Refined Equation May Obviate Oncotype DX in Breast Cancer Treatment Decisions
- Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis
- Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|